

Lisa Hoffmann-Haas
123 posts




Don't miss your chance to hear from these experts the latest developments in antigen discovery, preclinical and clinical advances in cancer vaccine therapies. brought to you by @moderna_tx & @NatureCancer Reserve your spot: go.nature.com/3rOUk2L













Attending “Immune Responses & DNA Repair” in beautiful Florence 🇮🇹 this week? Don’t miss the chance to meet our Senior Editor @LisaHaas0107 to discuss your work and all things related to publishing at @NatureCancer. #EASImmuneResponses @EACRnews @AACR







💫Recruiting, securing funding, building a network – early career investigators face many challenges! In “The 2022 generation” hear the inspiring stories of 12 PIs who started their teams in the past year. #newPI #2022InReview nature.com/articles/s4301… rdcu.be/c1Ymf

💫 OUR FAVOURITE TIME OF THE YEAR HAS ARRIVED 💫 As 2022 comes to an end @NatureCancer is proud to present our Focus Issue #2022InReview! DON'T MISS all of its exciting content right here 👇 nature.com/collections/ca…







Our @NatureCancer Editor @LisaHaas0107 is attending the #CRCL Symposium in Lyon 🇫🇷. Approach her to discuss your work 🧪💊and everything you want to know about publishing in @NatureCancer! #CancerResearch #CRCLSymposium #Cancerconference

📢OUR @NatureCancer EDITORIAL TEAM IS GROWING – apply to our 🔥-new position and join our team in NY, Philadelphia & Washington DC in the US; Berlin, London, Madrid in Europe; Shanghai in Asia 🌍. Application deadline October 28th. Please RT! Details 👉bit.ly/3rh2lJZ

📢HAPPENING TODAY - 5 more hours left to sign up and hear about cancer #organoids and #tumors on a chip from @KarunaMDPhD and @GVNlab. Join us for the talks and a live Q&A. Registration is FREE 👇 bit.ly/3DCRJwt